µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© E+:.IuXW$
$}V7(wu 6@
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 6/VNuQ_#
1¡¢Co-stimulators (or co-stimulating molecules) QZ?O;K1|y
2¡¢NK-kB j,
Pwket
3¡¢Immunoglobulin superfamily Th_Q
owk
4¡¢antigen-presenting cell (APC) a (P^e)<
5¡¢death domain 5Zzr5WM
6¡¢CCR and CXCR ]v<d0"2
7¡¢Lectin (or mitogen) d\\r_bGW
8¡¢Clusters of differentiation, CD) Al=(sHc'
9¡¢B7 family 4,gol?a
10¡¢Cytotoxic T lymphocyte, CTL) 56"#Syj
11¡¢IL-15 and IL-15 receptor (IL-15R) p1Y
+
12¡¢MHC restriction .@fK;/OuC
13¡¢Affinity-chromatography 7s0)
3HR}
14¡¢Cyctosprin A, CsA mu 2
A% "7
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) m*\B2\2gJ
w 9/nVu
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© xi;/^)r
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 Pb
bXi
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ \8=e|a5`
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ ~8XX3+]z:X
Rrh<mo(yj#
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© e$ThSh\+(
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ MFf05\aDu
ѪҺ²¡Ñ§×¨Òµ£º Oqd"0Qt-
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿